Medicare expands who can authorize diabetic shoes for patients
S. 1805 — Promoting Access to Diabetic Shoes Act · Filed by Susan Collins (R-ME) · 7 cosponsors · Introduced May 19, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill allows nurse practitioners and physician assistants to sign off on the medical documentation required for Medicare to cover therapeutic shoes for diabetic patients. Currently, only physicians can authorize this coverage; the bill expands that authority to two additional categories of licensed clinicians who commonly treat diabetic patients in primary care and endocrinology settings.
Why we flagged it
The bill's sole function is to broaden the pool of clinicians authorized to document medical necessity for a specific Medicare benefit, removing a credentialing bottleneck that delays patient access to therapeutic footwear.
What the text implies
- Reduces administrative delays for diabetic patients seeking shoe coverage by allowing them to obtain authorization from nurse practitioners and physician assistants, who are often more readily available in primary care and community health settings.
- May modestly increase Medicare claims volume for diabetic shoes if the expanded clinician pool reduces documentation gatekeeping, though the underlying medical need is unchanged.
The full analysis lists 3 implications of this text.
Who stands to gain
orthopedic shoe manufacturers and suppliers (modest volume increase); diabetic patients (reduced out-of-pocket delays and access friction)